FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Tells 21 Web Sites to Stop Selling Opioids

FDA tells four more online networks operating 21 Web sites to stop selling unapproved and misbranded versions of opioid drugs.

Human Drugs

Recognize Auryxia Regulatory Exclusivity: Keryx Petition

Keryx asks FDA to recognize two forms of exclusivity for its Auryxia ferric citrate drug.

Medical Devices

FDA Clears Add-on to Ceterix Orthopedics Meniscal Repair

FDA clears a Ceterix Orthopedics 510(k) for an added feature to the NovoStitch Pro Meniscal Repair System a size 0 suture cartridge.

Biologics

Haemonetics Recalls 10 Lots of Leukotrap RC System

Haemonetics recalls 10 lots of their Leukotrap RC System with RC2D Filter, intended for collecting whole blood and preparation of red blood cells and ...

Marketing

False, Misleading EstroGel Sell Sheet: OPDP

CDERs Office of Prescription Drug Promotion says a professional sell sheet for Ascends EstroGel contains false and misleading claims that it contains ...

Human Drugs

Mixed Reaction to Mexico Biological Drug Trade Deal

Representatives of innovator and generic drug companies disagree on the value of a 10-year drug exclusivity provision in the trade agreement with Mexi...

Human Drugs

End Unethical, Reckless NIH Sepsis Trial: Public Citizen

Public Citizens call for an end to the NIH-funded CLOVERS trial it says has serious regulatory and ethical lapses.

Human Drugs

Appeals Court Backs Eyedrop Suit Dismissal

The 1st Circuit Appeals Court backs a federal district court decision that a suit seeking to use state laws to force prescription eye drop manufacture...

Human Drugs

Reflection Biotechnologies Orphan Drug Designation

FDA grants Reflection Biotechnologies an orphan drug designation for RBIO-101, an adeno-associated virus gene therapy product for treating Bietti's Cr...

FDA General

Latest FDA Warning Letter

FDA releases its latest batch of Warning Letters that includes one medical product company Kelley-Ross Compounding.